$VSTM Headlines Stocks to watch Thursday: Green Mountain,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$VSTM Headlines

Stocks to watch Thursday: Green Mountain, Merck 6:55 a.m. Feb. 2, 2012 - MarketWatch
A busy IPO year as Facebook buzz builds 4:46 p.m. Jan. 30, 2012 - Benjamin Pimentel
Verastem climbs in early post-IPO trading 10:55 a.m. Jan. 27, 2012 - MarketWatch.com

Investments On Biotech's Cutting Edge: Joseph Pantginis 4:41 p.m. Nov. 18, 2013 - Seeking Alpha
10-Q: VERASTEM, INC. 7:21 a.m. Nov. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
Should You Follow Insiders On These 3 Stocks? 6:58 p.m. Nov. 4, 2013 - Seeking Alpha
Killing Cancer Stem Cells: The Final Battle? 2:48 p.m. Oct. 27, 2013 - Seeking Alpha
Novel Therapies and Defeating Multi-Drug Resistance Key in Success of Cancer Drug Companies 12:01 p.m. Oct. 23, 2013 - Wall St. Cheat Sheet
Will Galena's Initiatives Translate Into Positive Returns? 4:09 p.m. Sept. 28, 2013 - Seeking Alpha
Verastem Begins Phase 2 Trial of Defatinib in Lunc Cancer 7:37 a.m. Sept. 26, 2013 - benzinga.com
Verastem Initiates Defactinib Trial in Japan 5:04 a.m. Sept. 24, 2013 - benzinga.com
Verastem: An Attractive Long-Term Investment In The Cancer Stem Cell Space 5:12 a.m. Sept. 17, 2013 - Seeking Alpha
Verastem Issued U.S. Patent Covering VS-4718 Composition of Matter 5:01 a.m. Aug. 15, 2013 - benzinga.com
10-Q: VERASTEM, INC. 8:19 a.m. Aug. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
6 Reasons ImmunoCellular Therapeutics Is One Of The Best Risk Vs. Rewards In The Market 9:00 a.m. Aug. 7, 2013 - Seeking Alpha
6 Oncology-Focused Biotech Growth Engines: Mara Goldstein 5:01 p.m. Aug. 2, 2013 - Seeking Alpha
UPDATE: Jefferies Initiates Verastem at Buy on Cancer Research Potential 7:23 a.m. July 29, 2013 - benzinga.com
Verastem Receives Orphan Drug Designation from the U.S. FDA for Defactinib in Mesothelioma 5:08 a.m. July 24, 2013 - benzinga.com
Verastem Drug Achieves a Complete Response in Platinum-Resistant Ovarian Cancer 5:16 a.m. July 23, 2013 - benzinga.com
Verastem Announces Pricing of Public Offering of Common Stock At $15 7:25 a.m. July 17, 2013 - benzinga.com
Verastem Announces Proposed Public Offering of Common Stock 2:09 p.m. July 16, 2013 - benzinga.com
UPDATE: Oppenheimer Lowers PT on Verastem Following Analyst Day 6:32 a.m. July 12, 2013 - benzinga.com
Verastem Presents Results and Updated Development Plans 2:59 p.m. July 11, 2013 - benzinga.com


Verastem to Present at Upcoming Conferences 7:00 a.m. Nov. 26, 2013 - BusinessWire
Verastem Reports Third Quarter 2013 Financial and Corporate Results 7:00 a.m. Nov. 12, 2013 - BusinessWire
Verastem Names Jose Baselga, M.D., Ph.D. as Senior Medical Advisor 6:00 a.m. Oct. 31, 2013 - BusinessWire
Verastem Announces Presentations at the 2013 World Conference on Lung Cancer 6:00 a.m. Oct. 24, 2013 - BusinessWire
Verastem Announces Presentation of VS-6063 Clinical and Preclinical Study Results at the 2013 AACR-NCI-EORTC International Conference 6:00 a.m. Oct. 21, 2013 - BusinessWire
Verastem Executives Featured at Boston-Area Biotechnology Events 6:00 a.m. Oct. 15, 2013 - BusinessWire
Verastem Announces Presentations at the 2013 AACR-NCI-EORTC International Conference 6:00 a.m. Oct. 10, 2013 - BusinessWire
Verastem Initiates Phase 2 Trial of Defactinib in Lung Cancer 8:36 a.m. Sept. 26, 2013 - BusinessWire
Verastem Initiates Trial of Defactinib in Japan 6:00 a.m. Sept. 24, 2013 - BusinessWire
Verastem Reports on Ongoing Trials at Cancer Advance at Harvard Medical School 3:00 p.m. Sept. 19, 2013 - BusinessWire
Verastem to Present at Upcoming Scientific and Investor Conferences 6:00 a.m. Sept. 18, 2013 - BusinessWire
Veristat to Assist on Adaptive Enrichment Trial for Verastem's Defactinib in Mesothelioma 4:12 p.m. Sept. 10, 2013 - BusinessWire
Verastem Initiates COMMAND: A Registration-Directed Trial of Defactinib in Patients with Mesothelioma 6:00 a.m. Sept. 10, 2013 - BusinessWire
Verastem to Present at Upcoming Conferences 6:00 a.m. Sept. 3, 2013 - BusinessWire
Verastem Issued U.S. Patent Covering VS-4718 Composition of Matter 6:00 a.m. Aug. 15, 2013 - BusinessWire
Verastem Reports Second Quarter 2013 Financial and Corporate Results 6:00 a.m. Aug. 13, 2013 - BusinessWire
Verastem to Present at the 2013 Wedbush Life Sciences Management Access Conference 6:00 a.m. Aug. 7, 2013 - BusinessWire
Verastem to Present at 2013 Forbes Global CEO Conference 6:00 a.m. Aug. 6, 2013 - BusinessWire
Baron and Budd Applauds the Development of a New Drug for the Treatment of Mesothelioma 3:57 p.m. July 31, 2013 - BusinessWire
RDInvesting Provides Investors with Free In-Depth Equity Reports on ACT, CYOU, VSTM and WFM 7:51 a.m. July 30, 2013 - ACCESSWIRE

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading
ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 2

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 4

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
TCL’s AI Vision: Immersive Living at IFA 2026

Updated Category News Views 1

AI and Displays: A Match Made in Tech Heaven Every so often, a company stands up at a tech fair and gives a glimpse into the next chapter of living, as TCL did at IFA 2026. This time, they're not just talking about screens; they're weaving them into the fabric of everyday life alongside AI capabilities. From sporting arenas to your living room, it's a vision of what could...

Continue Reading
See's Candies Data Breach Spurs Legal Scrutiny

Updated Category News Views 12

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Updated Category News Views 3

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 0

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading

Top 5 Most Recently Viewed Articles

BioCryst Pharmaceuticals Celebrates ORLADEYO's Landmark Approval

Updated Category News Views 152

BioCryst Pharmaceuticals Achieves Significant Reimbursement Milestone BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has made a significant stride in the healthcare market by securing reimbursement for ORLADEYO (berotralstat) across major European nations. This breakthrough follows a positive recommendation from the Zorginstituut Nederland, leading to ORLADEYO's approval...

Continue Reading
Zoom Communications Achieves Award for Broadcast Innovation Success

Updated Category News Views 296

Zoom Communications Triumphs with Emmy Award Recognition In an impressive showcase of innovation, Zoom Communications, Inc. (NASDAQ: ZM) has received the prestigious Engineering, Science & Technology Emmy® Award. This accolade honors the company's revolutionary Zoom for Broadcast technology, which plays a significant role in enhancing broadcast capabilities across...

Continue Reading
Israel Acquisitions Corp. Reaches New Heights in Stock Prices

Updated Category News Views 46

Israel Acquisitions Corp. Achieves Significant Stock Milestone In a remarkable turn of events, shares of Israel Acquisitions Corp. (ISRL) have soared to a 52-week high, trading at an impressive $11.21. This achievement signifies a crucial milestone in the company's journey, showcasing its robust performance over the past year. The rising confidence among investors is...

Continue Reading
Oculis Advances Transformative Eye Drop Therapy for DME

Updated Category News Views 138

Oculis’ Innovative Approach to Treat Diabetic Macular Edema Oculis Holding AG (Nasdaq: OCS), a pioneering biopharmaceutical company dedicated to enhancing eye health, has made significant strides in treating diabetic macular edema (DME) through its revolutionary OCS-01 eye drops. These high-concentration dexamethasone eye drops are formulated with Oculis' unique...

Continue Reading
Pony AI Inc. Secures Permit for Driverless Robotaxi Services

Updated Category News Views 208

Pony AI Inc. Achieves Major Milestone in Autonomous Mobility Pony AI Inc. has made headlines recently by receiving a permit to operate fully driverless commercial robotaxi services in various urban districts. This remarkable announcement came during a significant event focused on artificial intelligence, signaling an important transition in the way transportation services...

Continue Reading